Clinical Trial

Exercise Rehabilitation in Patients With Severe Cardiopulmonary Dysfunction on Extracorporeal Life Support

Enrolling by Invitation Early Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated January 24, 2025 (before its estimated May 2025 completion). Its status may not reflect the trial's current state.
Summary
Short-term and long-term consequences of severe cardiac and/or lung dysfunction can be increased use of sedation, prolonged bedrest and immobility causing severe loss of muscle mass which could be a risk for muscle weakness, osteoporosis, and lowered endurance. The goal of this study is to show how a structured rehabilitation program can exhibit better short-term and long-term outcomes on patients who are treated with extracorporeal membrane oxygenation (ECMO).
Trial Details
NCT Number NCT06792617
Lead Sponsor Institute for Extracorporeal Life Support
Conditions ExtraCorporeal Membrane Oxygenation (ECMO), Cardiopulmonary Function, Rehabilitation
Enrollment 40 participants
Start Date 2024-10-25
Primary Completion 2025-05 (estimated)
Study Completion 2025-12 (estimated)
Updated on ClinicalTrials.gov 2025-01-24